|
KDELC2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.757000E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.243900E-03 |
| Normal-vs-Stage2 |
3.458200E-03 |
| Normal-vs-Stage3 |
1.507810E-02 |
| Normal-vs-Stage4 |
5.460500E-03 |
| Stage1-vs-Stage2 |
4.124000E-01 |
| Stage1-vs-Stage3 |
8.928800E-01 |
| Stage1-vs-Stage4 |
3.957800E-01 |
| Stage2-vs-Stage3 |
4.658400E-01 |
| Stage2-vs-Stage4 |
9.831800E-01 |
| Stage3-vs-Stage4 |
4.585600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.958800E-03 |
| Normal-vs-AfricanAmerican |
6.376100E-02 |
| Normal-vs-Asian |
9.855700E-02 |
| Caucasian-vs-AfricanAmerican |
9.440800E-01 |
| Caucasian-vs-Asian |
4.956000E-01 |
| AfricanAmerican-vs-Asian |
7.173400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.612800E-04 |
| Normal-vs-Female |
8.716100E-03 |
| Male-vs-Female |
1.520160E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.659800E-03 |
| Normal-vs-Age(41-60Yrs) |
1.775740E-03 |
| Normal-vs-Age(61-80Yrs) |
1.049850E-02 |
| Normal-vs-Age(81-100Yrs) |
2.870600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.251400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.072200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.916800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.058200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.568600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.634200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.351600E-01 |
| Classical-VS-Follicular |
6.223500E-03 |
| Classical-VS-Other |
2.609600E-02 |
| Classical-VS-Normal |
2.371800E-02 |
| Tall-VS-Follicular |
1.080130E-02 |
| Tall-VS-Other |
2.055800E-02 |
| Tall-VS-Normal |
6.193400E-01 |
| Follicular-VS-Other |
2.020200E-01 |
| Follicular-VS-Normal |
1.213550E-04 |
| Other-VS-Normal |
1.384910E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.812600E-04 |
| Normal-vs-N1 |
1.598420E-02 |
| N0-vs-N1 |
6.004600E-01 |
|
|
